Recent News

559 News Items found
Charles Sawyers and Elizabeth Wasmuth
The pictures provide new clues about how the androgen receptor interacts with cancer-causing proteins.
Memorial Sloan Kettering Cancer Center (MSK) today announced the establishment of The Starr Foundation Program for Discovery Science
Memorial Sloan Kettering Cancer Center (MSK) today announced the establishment of The Starr Foundation Program for Discovery Science, a pioneering new initiative made possible by a generous $50 million gift from The Starr Foundation. The program will support the visionary work of scientists at the Sloan Kettering Institute (SKI), the research arm of MSK, by funding foundational laboratory research that will drive the next generation of cancer breakthroughs and ultimately improve the lives of people facing cancer around the world.
Three women standing next to each other in a lobby
The in-person event featured scientific talks from leading women in science, including winners of this year’s Kravis WISE fellowships.
MSK molecular imaging specialist Jan Grimm
In the Clinic
A new imaging approach relying on Cerenkov light could sometimes substitute for PET scans and improve diagnostic services in underserved areas.
An illustration of a fish fin touching a human finger
Sloan Kettering Institute scientists are using zebrafish to understand human skin cancer that attacks the hands and feet.
Dirk Remus and Richard Hite
The results of this collaborative project overturn some conventional wisdom about how the DNA repair process works.
A colorful pigeon standing in an urban setting.
With the resurgence of interest in cancer metabolism, researchers are coming to realize that there is more to a cell’s biochemistry than once thought.
Memorial Sloan Kettering MERIT Sawyers Fellowship recipient Chris Bourne
Chris Bourne is the first recipient of the MERIT Sawyers Fellowship.
colorful picture of cancer cells
Data from 25,000 patients is helping scientists answer this and many other important questions.
Lab worker dressed in “bunny suit” working with machine.
A new type of engineered immune cell could be a potent treatment for cancers that have escaped other immunotherapies.